Balaxi Pharmaceuticals Limited (BALAXI.NS)
INR 79.69
(0.59%)
INR 79.69
(0.59%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -446.29 Million INR | -199.32% |
| 2022 | -149.1 Million INR | -319.44% |
| 2021 | -35.54 Million INR | -278.62% |
| 2020 | 19.9 Million INR | 164.67% |
| 2019 | -30.77 Million INR | -1746.46% |
| 2018 | 1.86 Million INR | 111.57% |
| 2017 | -16.15 Million INR | 29.88% |
| 2016 | -23.04 Million INR | -117138.17% |
| 2015 | 19.68 Thousand INR | -15.33% |
| 2014 | 23.25 Thousand INR | 100.64% |
| 2013 | -3.62 Million INR | 1.43% |
| 2012 | -3.67 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 625.71 Million INR | 240.2% |
| 2023 FY | -446.29 Million INR | -199.32% |
| 2023 Q4 | -446.29 Million INR | -258.58% |
| 2023 Q3 | 281.43 Million INR | 399.1% |
| 2023 Q2 | -94.09 Million INR | -133.06% |
| 2023 Q1 | 284.64 Million INR | 290.91% |
| 2022 FY | -149.1 Million INR | -319.44% |
| 2022 Q4 | -149.1 Million INR | -241.74% |
| 2022 Q3 | 105.19 Million INR | 227.48% |
| 2022 Q2 | -82.52 Million INR | -211.86% |
| 2022 Q1 | 73.77 Million INR | 307.53% |
| 2021 Q4 | -35.54 Million INR | -199.45% |
| 2021 FY | -35.54 Million INR | -278.62% |
| 2021 Q3 | 35.74 Million INR | 244.65% |
| 2021 Q2 | -24.71 Million INR | -248.06% |
| 2021 Q1 | 16.69 Million INR | -16.14% |
| 2020 Q3 | 31.65 Million INR | 200.0% |
| 2020 Q4 | 19.9 Million INR | -37.13% |
| 2020 Q2 | -31.65 Million INR | -176.85% |
| 2020 FY | 19.9 Million INR | 164.67% |
| 2020 Q1 | 41.19 Million INR | 202.97% |
| 2019 FY | -30.77 Million INR | -1746.46% |
| 2019 Q4 | -40 Million INR | -141.15% |
| 2019 Q3 | 97.22 Million INR | 200.0% |
| 2019 Q1 | 1.32 Million INR | 200.0% |
| 2019 Q2 | -97.22 Million INR | -7410.56% |
| 2018 FY | 1.86 Million INR | 111.57% |
| 2018 Q3 | 9.51 Million INR | 200.0% |
| 2018 Q4 | -1.32 Million INR | -113.97% |
| 2018 Q1 | 16.46 Million INR | 200.0% |
| 2018 Q2 | -9.51 Million INR | -157.82% |
| 2017 Q2 | -19.32 Million INR | -183.9% |
| 2017 Q3 | 19.32 Million INR | 200.0% |
| 2017 Q4 | -16.46 Million INR | -185.16% |
| 2017 FY | -16.15 Million INR | 29.88% |
| 2017 Q1 | 23.03 Million INR | 199.98% |
| 2016 Q3 | 91.42 Thousand INR | -96.62% |
| 2016 FY | -23.04 Million INR | -117138.17% |
| 2016 Q4 | -23.04 Million INR | -25306.08% |
| 2016 Q2 | 2.7 Million INR | 1265.94% |
| 2016 Q1 | 198.24 Thousand INR | 906.87% |
| 2015 FY | 19.68 Thousand INR | -15.33% |
| 2015 Q4 | 19.68 Thousand INR | 0.0% |
| 2014 FY | 23.25 Thousand INR | 100.64% |
| 2014 Q4 | 23.25 Thousand INR | 0.0% |
| 2013 FY | -3.62 Million INR | 1.43% |
| 2012 FY | -3.67 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|